OIP5 and endometrial carcinoma: Although there was no reports of OIP5-AS1 regulating SLC3A2/SLC7A5 in OA, study have demonstrated that in endometrial carcinoma cells, OIP5-AS1 can upregulate the expression of SLC7A5 by targeting miR-152-3p, thereby promoting cell proliferation [63].